Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (309)
- Scheduling (national classification system) (165)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
580 result(s) found, displaying 426 to 450
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Corporate reportsThe Australian Government response to the Mesh Senate inquiry has been published.
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 11 statement
-
Scheduling decisions (final)Revised final decisions for matters referred to the March 2018 ACMS/ACCS meetings and delegate-only decisions on agricultural chemicals and NCEs.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 October 2018
-
Meeting statementsThe Advisory Committee on Medicines meeting statement is now available
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 19 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in March 2018
-
Corporate reportsPost-market vigilance statistics for 2017
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsAbout compositional guidelines for ingredients permitted for use in listed medicines.
-
Corporate reportsThis guideline is an internationally accepted standard for the designing, conducting, recording and reporting of clinical trials.
-
Scheduling decisions (final)Delegate only final scheduling decisions on NCEs now available
-
Scheduling decisions (interim)Interim decisions to amend, or not amend, the Poisons Standard with respect to substances referred to the March 2018 ACMS/ACCS now available
-
Meeting statementsACM meeting statement, meeting 8, April 2018
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to the ACMS#18, July 2016 (interim decision)
-
-
Scheduling submissionsPublic submissions on matters referred to the July 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available